Norges Bank
FLNA

Norges Bank’s Filana Therapeutics FLNA Stock Holding History

Norges Bank’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,747
Closed -$346K – 1898
2024
Q3 		$346K Sell
11,747
-135,892
-92% -$3.13M ﹤0.01% 1808
2024
Q2 		$1.82M Sell
147,639
-52,033
-26% -$1.1M ﹤0.01% 1733
2024
Q1 		$4.05M Sell
199,672
-16,831
-8% -$388K ﹤0.01% 1653
2023
Q4 		$4.87M Hold
216,503
– – ﹤0.01% 1682
2023
Q3 		$3.6M Sell
216,503
-58,582
-21% -$1.16M ﹤0.01% 1740
2023
Q2 		$6.75M Hold
275,085
– – ﹤0.01% 1645
2023
Q1 		$6.64M Sell
275,085
-54,957
-17% -$1.52M ﹤0.01% 1687
2022
Q4 		$9.75M Buy
330,042
+36,003
+12% +$1.29M ﹤0.01% 1581
2022
Q3 		$12.3M Hold
294,039
– – ﹤0.01% 1450
2022
Q2 		$8.27M Buy
294,039
+4,198
+1% +$106K ﹤0.01% 1627
2022
Q1 		$10.8M Hold
289,841
– – ﹤0.01% 1679
2021
Q4 		$12.7M Hold
289,841
– – ﹤0.01% 1668
2021
Q3 		$18M Buy
+289,841
New +$24.2M ﹤0.01% 1547

Other funds holding FLNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Norges Bank's FLNA Position: Q4 2024 in Review

Norges Bank sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 11,747 shares — an estimated $346K sold.

Norges Bank first reported a position in FLNA in Q3 2021 and held it in 13 quarters. The position peaked at $18M in Q3 2021. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Norges Bank reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Norges Bank sold 11,747 Filana Therapeutics shares in Q4 2024, an estimated $346K.
  • Norges Bank first reported a position in Filana Therapeutics in Q3 2021 and held it in 13 quarters.
  • Norges Bank's Filana Therapeutics position peaked at $18M in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Norges Bank's 13F filing for Q4 2024, filed 12 Feb 2025.